InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Dana Pizzuti, Chief Med and Dev Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 17 open-market SEC Form 4 transactions: 0 purchases worth $0 and 17 sales worth $6.9M, reported from Apr 5, 23 to Dec 1, 25. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 1, 25 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 5.0K | $45.02 | $225K |
| Nov 3, 25 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 4.9K | $43.27 | $209K |
| Oct 1, 25 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 5.0K | $41.81 | $209K |
| Sep 2, 25 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 5.0K | $32.10 | $161K |
| Aug 22, 25 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 30.0K | $30.43 | $913K |
| Aug 20, 25 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 6.5K | $29.18 | $189K |
| Mar 19, 25 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 2.4K | $34.83 | $82K |
| Feb 3, 25 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 5.0K | $39.07 | $195K |
| Jan 3, 25 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 15.0K | $52.09 | $781K |
| Oct 3, 24 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 14.4K | $54.63 | $785K |
| Jul 3, 24 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 14.4K | $44.87 | $645K |
| Jun 24, 24 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 9.5K | $45.73 | $434K |
| Apr 15, 24 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 14.4K | $44.47 | $639K |
| Mar 20, 24 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 10.0K | $45.89 | $433K |
| Jan 3, 24 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 14.4K | $35.00 | $503K |
| Dec 21, 23 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 9.6K | $34.57 | $331K |
| Apr 5, 23 | CRNXCrinetics Pharmaceuticals, Inc. | SELL | 8.2K | $16.15 | $133K |